A Randomized, Open-label, Single Dose, Three-way Crossover Clinical Trial to Investigate the Pharmacokinetics Incorporating a Comparison of Fed/Fasted Pharmacokinetics of HIP1402 in Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 31 May 2017
At a glance
- Drugs Tamsulosin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Pharmacokinetics
- Sponsors Hanmi Pharmaceutical
- 18 Mar 2017 Results presented at the 118th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
- 12 Oct 2016 Status changed from recruiting to completed.
- 16 Sep 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.